|
||
(Exact name of registrant as specified in its charter)
|
||
|
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
(Former name or former address, if changed since last report.)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Exhibit No.
|
|
Description
|
|
Opinion of Morgan, Lewis & Bockius LLP
|
|
|
Consent of Morgan, Lewis & Bockius LLP (included in Exhibit 5.1)
|
|
|
Press Release of the Company, dated December 9, 2022
|
|
104
|
|
Cover Page Interactive Data File (embedded with the Inline XBRL document)
|
December 9, 2022
|
ADMA Biologics, Inc.
|
||
|
|
||
|
By:
|
/s/ Brian Lenz
|
|
|
|
Name:
|
Brian Lenz
|
|
|
Title:
|
Executive Vice President and Chief Financial Officer
|